AMCR Institute Restructures Leadership
to Strengthen Service Quality,
Appoints Carmen J. Ostermeier as President & CDO

Escondido, CA, October 15, 2021 - AMCR Institute, Inc., an independent, fully dedicated clinical research site focused on Phase I-IV studies within diabetes, obesity, NAFLD/NASH, and vaccines, announced the promotion of Carmen J. Ostermeier, PharmD, to the position of President and Chief Development Officer (CDO). Ostermeier has been serving as CDO and provided critical and clear guidance and direction during the challenging pandemic. She will continue to lead all patient centric initiatives, our newly established diversity & inclusion program as well as site relationship optimization. Timothy S. Bailey, MD, FACE, CPI will continue as CEO & Founder.

"Our company is in the process of reevaluating internal structures and operational processes to adjust to the ongoing fast industry transformation to ensure highest quality of data delivery as timely and reliably as possible. Carmen’s promotion speaks to the priority of this for the company," said Timothy S. Bailey, CEO. “Carmen has played an integral role in the evolution of our company over the past four years. We are fortunate to have such a talented and extremely capable leader within our organization. I am extremely pleased to announce her promotion. I trust her with her new responsibilities and look forward to continuing to work together in the coming years as we grow the company."

Ostermeier has more than 30 years of combined international pharmaceutical industry and drug/device development experience and has successfully led teams in an academic, pharmaceutical wholesales, sales, and research environment. Several non-profit and healthcare organizations awarded her for her outstanding contributions as chairperson, committee member, advocate, public speaker, and volunteer.

About AMCR Institute

AMCR Institute is a globally recognized, independent clinical research site exclusively focused on diabetes, obesity, NAFLD/NASH, and vaccines. In addition to bio-pharmaceutical research, we conduct medical device trials from feasibility to pivotal. We are engaged in Phase I-IV trials in pediatric and adult populations. Through a solid network of referring physicians AMCR Institute has built a robust and comprehensive volunteer database for assembling ideal trial populations.

AMCR Institute is dedicated to attracting, nurturing, and retaining subjects and staff to carry out outstanding metabolic research. Volunteers, sponsors, partners, and staff enjoy working together in an environment of mutual respect that fosters personal growth and optimal health.

We strive to be the best at what we do and always be meticulous in all our practices placing the care, safety, and confidentiality of our volunteers first. We take pride delivering quality results on time, taking full responsibility for AMCR Institute’s part of your projects. For more information, please visit www.amcrinstitute.com.